Page last updated: 2024-08-05 11:22:19

ubiquinones

Any benzoquinone derived from 2,3-dimethoxy-5-methylbenzoquinone; one of a group of naturally occurring homologues. The redox-active quinoid moiety usually carries a polyprenoid side chain at position 6, the number of isoprenoid units in which is species-specific. Ubiquinones are involved in the control of mitochondrial electron transport, and are also potent anti-oxidants.

ChEBI ID: 16389

Members (9)

MemberDefinitionRole
3,4-dimethoxydalbergione(R)-3,4-Dimethoxydalbergione
coenzyme q10A ubiquinone having a side chain of 10 isoprenoid units. In the naturally occurring isomer, all isoprenyl double bonds are in the E- configuration.coenzyme Q10
ubiquinone 6A ubiquinone compound having a (2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl substituent at position 2.ubiquinone-6
ubiquinone 7A compound whose structure comprises a 2,3-dimethoxy-5-methylbenzoquinone nucleus, common to ubiquinones; and a side chain of seven isoprenoid units.ubiquinone-7
ubiquinone 8A ubiquinone whose structure comprises a 2,3-dimethoxy-5-methylbenzoquinone nucleus (common to all ubiquinones) and a side chain of eight isoprenoid units.ubiquinone-8
ubiquinone 9ubiquinone-9
ubiquinone q1A compound composed of the standard 2,3-dimethoxy-5-methylbenzoquinone nucleus common to ubiquinones; and a side chain of a single isoprenoid unit.ubiquinone-1
ubiquinone q2A compound composed of the 2,3-dimethoxy-5-methylbenzoquinone nucleus common to ubiquinones; and a side chain of two isoprenoid units.ubiquinone-2
ubiquinone-oA derivative of benzoquinone carrying a 5-methyl substituent; and methoxy substituents at positions 2 and 3. The core structure of the ubiquinone group of compounds.ubiquinone-0

Research

Studies (4,427)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990296 (6.69)18.7374
1990's457 (10.32)18.2507
2000's1,003 (22.66)29.6817
2010's2,207 (49.85)24.3611
2020's464 (10.48)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials458 (9.45%)5.53%
Reviews471 (9.72%)6.00%
Case Studies159 (3.28%)4.05%
Observational11 (0.23%)0.25%
Other3,748 (77.33%)84.16%